Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Kairos Pharma, Ltd. (KAPA) had Book Value Per Share of $1.37 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.39M |
|
-- |
|
-- |
|
$1.42M |
|
$-1.42M |
|
$0.03M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.42M |
|
$-1.18M |
|
3.06M |
|
3.06M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$3.17M |
|
-- |
|
$1.28M |
|
$4.46M |
|
$0.27M |
|
-- |
|
-- |
|
$0.27M |
|
$4.19M |
|
$4.19M |
|
$4.19M |
|
3.06M |
|
| Cash Flow Statement Financials | |
$-2.05M |
|
-- |
|
$0.18M |
|
$4.49M |
|
$2.63M |
|
$-1.86M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.12% |
|
-33.12% |
|
-31.15% |
|
-33.12% |
|
|
Book Value Per Share |
$1.37 |
$-0.67 |
|
$-0.67 |
|